AcelRx Pharmaceuticals announces proposed public offering of common stock
AcelRx Pharmaceuticals announced it intends to offer and sell shares of its common stock in an underwritten public offering. AcelRx expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. November 09, 2018